rs73996414

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000091.5(COL4A3):​c.4041C>A​(p.Asp1347Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00459 in 1,614,098 control chromosomes in the GnomAD database, including 256 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 146 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 110 hom. )

Consequence

COL4A3
NM_000091.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -2.27

Publications

7 publications found
Variant links:
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
MFF-DT (HGNC:41067): (MFF divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 8 uncertain in NM_000091.5
BP4
Computational evidence support a benign effect (MetaRNN=0.0026836097).
BP6
Variant 2-227304032-C-A is Benign according to our data. Variant chr2-227304032-C-A is described in ClinVar as Benign. ClinVar VariationId is 334780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0793 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000091.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
NM_000091.5
MANE Select
c.4041C>Ap.Asp1347Glu
missense
Exon 46 of 52NP_000082.2
MFF-DT
NR_102371.1
n.243+1428G>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
ENST00000396578.8
TSL:1 MANE Select
c.4041C>Ap.Asp1347Glu
missense
Exon 46 of 52ENSP00000379823.3
COL4A3
ENST00000469504.2
TSL:1
n.12C>A
non_coding_transcript_exon
Exon 1 of 6ENSP00000493493.1
MFF-DT
ENST00000439598.6
TSL:1
n.243+1428G>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0235
AC:
3579
AN:
152162
Hom.:
146
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0817
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00746
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00231
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.00640
AC:
1596
AN:
249314
AF XY:
0.00489
show subpopulations
Gnomad AFR exome
AF:
0.0837
Gnomad AMR exome
AF:
0.00418
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.00234
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000460
Gnomad OTH exome
AF:
0.00264
GnomAD4 exome
AF:
0.00262
AC:
3831
AN:
1461818
Hom.:
110
Cov.:
31
AF XY:
0.00230
AC XY:
1676
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.0814
AC:
2723
AN:
33472
American (AMR)
AF:
0.00459
AC:
205
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00134
AC:
35
AN:
26136
East Asian (EAS)
AF:
0.00123
AC:
49
AN:
39700
South Asian (SAS)
AF:
0.00128
AC:
110
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00607
AC:
35
AN:
5768
European-Non Finnish (NFE)
AF:
0.000313
AC:
348
AN:
1111984
Other (OTH)
AF:
0.00540
AC:
326
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
230
461
691
922
1152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0235
AC:
3584
AN:
152280
Hom.:
146
Cov.:
32
AF XY:
0.0225
AC XY:
1678
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0816
AC:
3390
AN:
41552
American (AMR)
AF:
0.00745
AC:
114
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00231
AC:
12
AN:
5184
South Asian (SAS)
AF:
0.00125
AC:
6
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
68016
Other (OTH)
AF:
0.0180
AC:
38
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
165
330
494
659
824
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00931
Hom.:
119
Bravo
AF:
0.0276
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.0827
AC:
330
ESP6500EA
AF:
0.000240
AC:
2
ExAC
AF:
0.00776
AC:
938
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.000654
EpiControl
AF:
0.00107

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
-
-
1
Alport syndrome (1)
-
-
1
Atypical hemolytic-uremic syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
6.1
DANN
Benign
0.89
DEOGEN2
Benign
0.24
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.078
N
LIST_S2
Benign
0.73
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
-0.16
N
PhyloP100
-2.3
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.33
N
REVEL
Benign
0.21
Sift
Benign
0.35
T
Sift4G
Benign
1.0
T
Polyphen
0.0020
B
Vest4
0.086
MutPred
0.23
Loss of catalytic residue at G1349 (P = 0.1665)
MVP
0.55
MPC
0.18
ClinPred
0.0031
T
GERP RS
-2.0
Varity_R
0.061
gMVP
0.047
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73996414; hg19: chr2-228168748; API